AdvaMed® Advancements: Q2 2025 Report
Discover our Q2 report highlighting key industry wins, tariff updates, and strategic progress driving medtech innovation and advocacy forward.
Government & Legislative Affairs
Learn more about our Advocacy work.
AdvaMed® Comments to HHS Deregulation RFI
AdvaMed® submitted public comments in response to HHS’s request for information on eliminating federal regulations that hinder economic growth, innovation, and American competitiveness.
The Kennedy v Braidwood Ruling: What’s Next for MedTech
JoinAdvaMed® and Reed Smith experts to explore how the Supreme Court’s ACA ruling in Braidwood could shape preventive care and MedTech policy.
AdvaMed® Statement on the Tax Bill
WASHINGTON – Today, AdvaMed, the MedTech Association®, released the following statement from President and CEO Scott Whitaker on the impact the “One Big Beautiful Bill Act” will have on medtech…
Medtech Goes to Capitol Hill
AdvaMed’s annual Medtech Showcase and Reception on Capitol Hill seeks to inform a core audience: the members of the Congress and their staff who enact the policies that help our…
Medtech is Essential: Industry Supports Call for Tariff Flexibility
AdvaMed® President and CEO Scott Whitaker testified before the U.S. Senate Finance Committee, bringing attention to the pressing issue of how tariffs could impact the medtech industry and, most importantly,…
URGENT: Court Ruling on Tariffs — Implications for Medtech
Emergency Briefing on Court Ruling on Tariffs and Its Impact on Medtech. Now On Demand!
AdvaMed® Welcomes Introduction of American Innovation and Jobs Act
WASHINGTON—AdvaMed, the MedTech Association®, welcomed introduction of the bipartisan Access to Prescription Digital Therapeutics Act of 2025 (S. 1702/H.R. 3288) by U.S. Sens. Shelley Moore Capito (R-W.Va.) and Jeanne Shaheen…
AdvaMed® Welcomes Introduction of Access to Prescription Digital Therapeutics Act
WASHINGTON—AdvaMed, the MedTech Association®, welcomed introduction of the bipartisan Access to Prescription Digital Therapeutics Act of 2025 (S. 1702/H.R. 3288) by U.S. Sens. Shelley Moore Capito (R-W.Va.) and Jeanne Shaheen…
AdvaMed® Welcomes the Re-Introduction of the Ensuring Patient Access to Critical Breakthrough Products Act
Washington, D.C.–AdvaMed President and CEO Scott Whitaker released the following statement upon re-introduction of bipartisan legislation aimed at accelerating Medicare coverage for breakthrough medtech and diagnostics. The Ensuring Patient Access…